These courses are intended for internal hospital staff.

Activity Description:

This Pediatric Oncology Tumor Board series is an interactive, multidisciplinary forum that is held on a monthly basis to present and discuss questions of best medical care of pediatric cancer patients. Peer reviewed data pertaining to diagnostic, therapeutic or management dilemmas are presented and discussed at this conference. Participants will discuss cases with rare cancer and unique presentations. Those patients with unforeseen complications will also be reviewed and discussed regarding best practices for patients.

Target Audience:

Medical Oncologists, Radiation Oncologists, Pediatricians, Pediatric subspecialists, Pediatric radiotherapists, and other child health care professionals, Pharmacists, Nurses, Social Workers, Occupational Therapists, Respiratory Therapists, Dietitians, Athletic Trainers, Patient Care Facilitators and all other personnel involved in the care of the pediatric patient.  

Learning Objectives:

Participants who engage in this educational intervention will be able to:

• Recognize the latest developments and treatment options in Pediatric Oncology.
• Identify new clinical, diagnostic, and therapeutic modalities to incorporate in their daily practice and care of children.
• Advance the knowledge and skills of pediatricians and pediatric specialists in the early recognition of pediatric oncologic diseases.
• Ability to promote and direct lectures, conferences, and literature reviews in Pediatric Oncology to pediatricians, pediatric subspecialists, and other child health care professionals.

Moderator:

Elaine Fan, MD

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Accreditation:

The HCA Healthcare Continental Division is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. 

Credit Designation:

The HCA Healthcare Continental Division designates this live activity for a maximum of 1.0 AMA PRA Category 1^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Commercial Support:  

This Activity was developed without support from any ineligible company.*The ACCME defines ineligible companies as those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. Note: The ACCME does not consider providers of clinical service directly to patients to be commercial interests – unless the provider of clinical services is owned, or controlled by, and ACCME defined ineligible company.

Disclosure: 

The HCA Healthcare Continental Division is committed to providing CME that is balanced, objective, and evidenced-based. In accordance with the Accreditation Council for Continuing Medical Education Standards for Integrity and Independence all parties involved in content development are required to disclose all conflicts of interest with ACCME defined ineligible companies. The HCA Healthcare Continental Division has identified, reviewed, and mitigated all conflicts of interest that speakers, authors, course directors, planners, peer reviewers, or relevant staff disclose prior to the delivery of any educational activity. The CME planning committee who are in a position to control the content of this CME Activity, have no relevant financial relationships with ineligible companies to disclose.